Recent insight into the role of FBXW7 as a tumor suppressor

Kanae Yumimoto, Keiichi I. Nakayama

研究成果: ジャーナルへの寄稿総説査読

45 被引用数 (Scopus)

抄録

FBXW7 (also known as Fbw7, Sel10, hCDC4, or hAgo) is a tumor suppressor and the most frequently mutated member of the F-box protein family in human cancers. FBXW7 functions as the substrate recognition component of an SCF-type E3 ubiquitin ligase. It specifically controls the proteasome-mediated degradation of many oncoproteins such as c-MYC, NOTCH, KLF5, cyclin E, c-JUN, and MCL1. In this review, we summarize the molecular and biological features of FBXW7 and its substrates as well as the impact of mutations of FBXW7 on cancer development. We also address the clinical potential of anticancer therapy targeting FBXW7.

本文言語英語
ページ(範囲)1-15
ページ数15
ジャーナルSeminars in Cancer Biology
67
DOI
出版ステータス出版済み - 12月 2020

!!!All Science Journal Classification (ASJC) codes

  • 癌研究

フィンガープリント

「Recent insight into the role of FBXW7 as a tumor suppressor」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル